StockData
Valion Bio, Inc. logo

Valion Bio, Inc. (VBIO) stock

VBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30
$0.54+0.01 (+2.72%)

Close on Nov 17, 2026Market cap $2.26MP/E –Yield –

Valion Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Valion Bio's price to sales ratio was 102.6× on Jan 30, 2026, against 38.4× a year earlier. Over the last 4 years it ranged from 6.6× to 401.3×, with a median of 64.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 2026102.6×−22.4
2025Dec 31, 2025125.1×+68.6
2024Dec 31, 202456.5×+2.7
2023Dec 29, 202353.8×−31.2
2022Dec 30, 202285.0×–

More Valion Bio figures

See a number that looks wrong?